TFS Capital’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-3,123
| Closed | -$32K | – | 1078 |
|
|
2015
Q4 | $32K | Buy |
+3,123
| New | +$32K | ﹤0.01% | 720 |
|
|
2015
Q2 | – | Sell |
-2,637
| Closed | -$47K | – | 1050 |
|
|
2015
Q1 | $47K | Sell |
2,637
-3,407
| -56% | -$60.7K | ﹤0.01% | 931 |
|
|
2014
Q4 | $111K | Sell |
6,044
-21,109
| -78% | -$388K | 0.01% | 904 |
|
|
2014
Q3 | $657K | Buy |
27,153
+25,607
| +1,656% | +$620K | 0.06% | 509 |
|
|
2014
Q2 | $56K | Sell |
1,546
-8
| -0.5% | -$290 | ﹤0.01% | 1074 |
|
|
2014
Q1 | $71K | Sell |
1,554
-1,176
| -43% | -$53.7K | ﹤0.01% | 1296 |
|
|
2013
Q4 | $106K | Buy |
+2,730
| New | +$106K | 0.01% | 1392 |
|